CURRICULUM VITAE ROBINNA GAIL LORENZ, M.D., Ph.D. Date: December 20, 2019 PERSONAL INFORMATION Name: Robinna (Robin) Gail Lorenz, M.D., Ph.D. Citizenship: United States of America Foreign Language(s): None Home Address: 2716 Isabelle Avenue San Mateo, CA 94403 Cell Phone: (205) 821-3237 e-mail: [email protected]RANK/TITLE: Senior Director Primary Department: Pathology Business Address: Genentech, Inc. 1 DNA Way, Mailstop 72B (room 10427-B) South San Francisco, CA 94080 Phone: (650) 467-2119 e-mail: [email protected]HOSPITAL AND OTHER (NON-ACADEMIC) APPOINTMENTS: 1994-2002 Attending Physician, Barnes-Jewish Hospital, St. Louis, Missouri 1996-2000 Lab Programming Committee, BJC Campus Integration Project, Barnes-Jewish Hospital, St. Louis, Missouri 1994-2002 Director, Joint Clinical Immunology Laboratory, Barnes-Jewish and St. Louis Children’s Hospitals, St. Louis, Missouri 1994-2002 Associate Director, Laboratory Medicine Residency Training Program, Barnes- Jewish Hospital, St. Louis, Missouri 1996-2002 Laboratory Medicine Resident Selection Committee, Barnes-Jewish Hospital, St. Louis, Missouri 2002-2018 Medical Staff, University of Alabama Health System, Birmingham, AL (including UAB Highlands beginning in 2006) 2002-2014 Medical Staff, VA Medical Center, Birmingham, AL 2003-2008 Associate Director, Pathology Residency Program, University of Alabama Health System, Birmingham, AL
Transcript
CURRICULUM VITAE ROBINNA GAIL LORENZ, M.D., Ph.D.
Date: December 20, 2019 PERSONAL INFORMATION Name: Robinna (Robin) Gail Lorenz, M.D., Ph.D. Citizenship: United States of America Foreign Language(s): None Home Address: 2716 Isabelle Avenue San Mateo, CA 94403 Cell Phone: (205) 821-3237 e-mail: [email protected] RANK/TITLE: Senior Director Primary Department: Pathology
Business Address: Genentech, Inc. 1 DNA Way, Mailstop 72B (room 10427-B) South San Francisco, CA 94080
Phone: (650) 467-2119 e-mail: [email protected] HOSPITAL AND OTHER (NON-ACADEMIC) APPOINTMENTS: 1994-2002 Attending Physician, Barnes-Jewish Hospital, St. Louis, Missouri 1996-2000 Lab Programming Committee, BJC Campus Integration Project, Barnes-Jewish
Hospital, St. Louis, Missouri
1994-2002 Director, Joint Clinical Immunology Laboratory, Barnes-Jewish and St. Louis Children’s Hospitals, St. Louis, Missouri
1994-2002 Associate Director, Laboratory Medicine Residency Training Program, Barnes-
Jewish Hospital, St. Louis, Missouri
1996-2002 Laboratory Medicine Resident Selection Committee, Barnes-Jewish Hospital, St. Louis, Missouri
2002-2018 Medical Staff, University of Alabama Health System, Birmingham, AL (including
UAB Highlands beginning in 2006) 2002-2014 Medical Staff, VA Medical Center, Birmingham, AL 2003-2008 Associate Director, Pathology Residency Program, University of Alabama Health
System, Birmingham, AL
p. 2 of 45 Robinna G. Lorenz
2015-2018 Medical Staff, Baptist Medical Center East / South, Montgomery, AL 2015-2018 Medical Staff, Regional Medical Center, Anniston, AL 2016-2018 Section Head, Clinical Immunology Laboratory, University Hospital, University of
Alabama at Birmingham, Birmingham, AL 2017-2018 Medical Staff, Children’s of Alabama Hospital, Birmingham, AL EDUCATION: Institution Degree Month/Year
Washington University Ph.D., Immunology 6/1990 Washington University M.D. 6/1990 Stanford University B.S., Biological Sciences 6/1984 University of Alabama M.S., Healthcare Quality 8/2017 at Birmingham and Safety
MILITARY SERVICE: None LICENSURE: Missouri (Physician) May, 1994 Alabama (Physician) May, 2002 BOARD CERTIFICATION: American Board of Pathology (Clinical Pathology) July, 2003 (ABPath ID: 26301) CLINICAL TRAINING: Month/Year Position Institution 7/1990-6/1994 Laboratory Medicine Barnes-Jewish Hospital Resident POSTDOCTORAL TRAINING: Month/Year Position Institution 7/1991-6/1993 Post-doctoral Fellow Washington University PROFESSIONAL DEVELOPMENT: Year Activity
p. 3 of 45 Robinna G. Lorenz
2015 Take the Lead on Healthcare Quality Improvement – Coursera
(Case Western Reserve University) 2014-2015 Executive Leadership in Academic Medicine (ELAM) (Drexel
University) 2014 Leading Strategic Innovation in Organizations – Coursera
(Vanderbilt University) 4/2016 Certificate, Healthcare Quality and Safety (University of Alabama
at Birmingham) 8/2016-08/2017 Master of Science in Healthcare Quality and Safety (University of
Alabama at Birmingham) 10/2019 Accelerated Leadership Program (ALP) (Genetech/Roche) POSITIONS/ACADEMIC APPOINTMENTS: Month/Year Position Institution 04/2019 – Present Adjunct Professor Pathology
University of California-San Francisco
04/2019 – Present Adjunct Professor Pathology Stanford University 07/2018 – Present Senior Director Research Pathology Genentech, Inc. 08/2018 – Present Adjunct Professor Pathology Univ. of Alabama at Birmingham 10/2015 – 12/2015 Interim Associate Dean Graduate Biomedical Sciences Univ. of Alabama at Birmingham School of Medicine 08/2015 – 7/2018 Director Physician Scientist Development Office Univ. of Alabama at Birmingham School of Medicine 08/2015 – 7/2018 Associate Dean Physician Scientist Development
p. 4 of 45 Robinna G. Lorenz
Univ. of Alabama at Birmingham School of Medicine 04/2013-07/2015 Assistant Dean Physician-Scientist Education Univ. of Alabama at Birmingham School of Medicine 10/2012-7/2018 Professor with Tenure Medical Education Univ. of Alabama at Birmingham 10/2007-7/2018 Professor with Tenure Pathology and Microbiology Univ. of Alabama at Birmingham 4/2003-7/2018 Scientist Comprehensive Cancer Center Tumor Immunology Program Univ. of Alabama at Birmingham 10/2003-2007 Associate Professor Pathology with Tenure Univ. of Alabama at Birmingham 8/2002-7/2018 Member UAB Graduate Faculty -Integrative Biomedical Sciences -Cellular and Molecular Biology -Molecular and Cellular Pathology -Microbiology 7/2002-9/2007 Associate Professor Pathology
Univ. of Alabama at Birmingham 7/2002-9/2007 Associate Professor Microbiology
Univ. of Alabama at Birmingham 7/1994-6/2002 Assistant Professor Pathology and Immunology
Washington University AWARDS/HONORS: 1984 Graduated with department honors, Stanford University, Stanford, California.
1985 George F. Gill Prize in Anatomy, Washington University School of Medicine,
St. Louis, Missouri.
1985 Kehar S. Chouke Prize in Anatomy, Washington University School of Medicine, St. Louis, Missouri.
p. 5 of 45 Robinna G. Lorenz
1984-1990 Medical Scientist Training Program Fellow, Washington University School of Medicine, St. Louis, Missouri.
1988 Spencer T. and Ann W. Olin Medical Fellow, Washington University School of
Medicine, St. Louis, Missouri.
1990-1994 Post-Graduate Medical Scientist Training Program Fellow, Washington University School of Medicine, St. Louis, Missouri.
1995-1998 Charles E. Culpepper Medical Scholar 1999-2006 American Cancer Society Research Scholar 2006 Ellis Benson Award (in recognition of outstanding Achievements in Clinical
Pathology), Academy of Clinical Laboratory Physicians and Scientists, Chicago, IL
2006 Award for Excellence in Resident Education in Clinical Pathology, Pathology Residency Program, University of Alabama at Birmingham
2006-2009 Sandler Program for Asthma Research Early Excellence Investigator/Fellow of the
American Asthma Foundation 2008 Dean’s Award for Excellence in Mentorship, University of Alabama at Birmingham,
Birmingham, AL 2011 Dean’s Award for Excellence in Educational Leadership, University of Alabama at
Birmingham, Birmingham, AL 2013 Alumni Recognition Award, Okeene High School, Okeene, OK 2014 Alpha Omega Alpha Honor Medical Society, Faculty Inductee 2014-2015 Fellow, Hedwig van Ameringen Executive Leadership in Academic Medicine
(ELAM) Program for Women 2015 President’s Award for Excellence in Teaching, Joint Health Sciences, University of
Alabama at Birmingham, Birmingham, AL 2016 American Society for Investigative Pathology (ASIP) Robbins Distinguished
Educator Award 2018 Disability Support Services Outstanding Faculty Award, Spring 2018, University of
Alabama at Birmingham, Birmingham, AL 2018 Bert Shapiro Award for Outstanding Contributions to Physician-Scientist Training,
National Association of MD-PhD Programs
p. 6 of 45 Robinna G. Lorenz
2019 Gerald T. Evans Award for Outstanding Leadership and Service to the Academy,
Academy of Clinical Laboratory Physicians and Scientists (ACLPS) PROFESSIONAL SOCIETIES AND MEMBERSHIPS: 1994 American Society for Microbiology 1995 Academy of Clinical Laboratory Physicians and Scientists 1996 American Association of Immunologists 1996 Association of Medical Laboratory Immunologists 1996 Society for Mucosal Immunology 1996 Clinical Immunology Society 1997 American Association for Clinical Chemistry 1998 American Gastroenterology Association 2003 American Society for Investigative Pathology 2004 College of American Pathologists 2004 American Society for Clinical Pathology 2007 The Histochemical Society PROFESSIONAL CONSULTANTSHIPS: External Advisory Board: Dartmouth MD/PhD Training Program, Hanover, NH (2013) Wayne State MD/PhD Training Program, Detroit, MI (2012) University of Minnesota Medical Scientist Training Program, Minneapolis, MN (2012-2016)
Vanderbilt Medical Scientist Training Program, Nashville, TN (2012) University of Texas at San Antonio MD/PhD Program, San Antonio, TX (2012) University of Texas – Houston/MD Anderson Cancer Center MD/PhD Program, Houston, TX (2013) Baylor College of Medicine MSTP, Houston, TX (2013) University of Florida MD/PhD Program, Gainesville, TX (2014) University of Iowa Medical Scientist Training Program, Iowa City, IA (2014, 2016) University of California, San Francisco Medical Scientist Training Program (2014, 2019) Emory University Medical Scientist Training Program, Atlanta, GA (2015) Northwestern University Medical Scientist Training Program, Chicago, IL (2015) Icahn School of Medicine at Mount Sinai Medical Scientist Training Program, New York, NY (2016) University of North Carolina Translational Medicine Graduate Program, Chapel Hill, NC (2016) University of Texas at Houston, CTSA External Advisory Board for Training, Houston, TX (2016, 2017) Mayo Clinic Medical Scientist Training Program, Rochester, MN (2016) University of California Los Angeles-Caltech Medical Scientist Training Program (2016) University of Pennsylvania Medical Scientist Training Program, Philadelphia, PA (2017) University of Chicago Medical Scientist Training Program, Chicago, IL (2017) University of Rochester Medical Scientist Training Program, Rochester, NY (2017)
p. 7 of 45 Robinna G. Lorenz
University of North Carolina Medical Scientist Training Program, Raleigh, NC (2018) Washington University School of Medicine Medical Scientist Training Program, St. Louis, MO (2018) Texas A&M College of Medicine MD-PhD Program, Bryan, Texas (2019)
COUNCILS AND COMMITTEES: National National Institutes of Health:
International and Cooperative Projects (ICP) Study Section, October 1999 Special Study Section on Infectious Etiology of Chronic Diseases, November 2001 Special Emphasis Panel on Nutrients Uptake and Intestinal Immunity, December 2002 Special Emphasis Panel on Different Bacterial Species Selective Induce TH1 Cells, July
2003 Special Emphasis Panel for Member Conflict Applications (CIGP, GCMB, GMPB, and
HBPP), March 2004, June 2004, June 2005, June 2006, October 2006, March 2007, October 2007, June 2008
Special Emphasis Panel, K01 & K08 Awards Applications Reviews, June 2004, November 2004
Tumor Microenvironment (TME) Study Section, June 2005 Skeletal Biology Structure and Regeneration Study Section, February 2006 Gastrointestinal Mucosal Pathobiology (GMPB) Study Section, June 2006 Special Emphasis Panel for PO1 Application (TH2 lymphocytes), June 2007 Biomedical Research and Research Training Review Subcommittee (BRT-5) Study Section, November 2007, ad hoc member Special Emphasis Panel for NIH Challenge Grants, ZRG DKUS-A(58), July 2009 NIDDK Study Section DDK-C Ad-hoc reviewer, March 2010 Special Emphasis Panel for NIH NIGMS Institutional Research and Academic Career
Development Awards (IRACDA), March 2012 Biomedical Research and Research Training Subcommittee B (BRT), National Institute
of General Medical Sciences (NIGMS) member, July 2008 – June 2015, BRT-X Chair (November 2009) (NOTE: this committee is now known as the Training, Workforce, Diversity and Development Subcommittee A (TWD-A)), TWD-A Chair July 2013 – June 2015; Ad-hoc reviewer November 2018, June 2019
Organizing Committee, NIH/NIGMS MSTP 50th Anniversary Symposium, July 17, 2014, Washington DC
NIDDK / DDK-C (Digestive Diseases and Nutrition C) Review Panel, 2016 - 2017 (Ad Hoc Reviewer), 2017-2021 (Standing Member)
Pilot Approaches to Enhance the Physician-Scientist Workforce Workshop, February 20, 2016, Washington DC, invited participant
Clinical and Translational Science Award (CTSA) Special Emphasis Panel (SEP), NIH/NCATS September 2017, Washington DC (Reviewer)
NHLBI Division of Cardiovascular Sciences Advisory Panel for Diversity Training Programs, May 9, 2018, Washington DC
p. 8 of 45 Robinna G. Lorenz
Academy of Clinical Laboratory Physicians and Scientists:
Committee, October 2004-2006 Nominating and Awards Committee, 2007-2008 Executive Council, 2010-2015 President-Elect and Chair, Program and Finance Committee, 2012-2013 President, 2013-2014 Past-President and Chair, Awards and Nomination Committee, 2014-2015 ACLPS Paul E. Strandjord Young Investigator Grant Review Committee, 2015, 2016 Member, Program and Finance Committee, 2016-2017
American Association for Cancer Research (AACR): Pathology Task Force (2018-present): Chair, Communication/Rebranding & Education/Training Subcommittee
Member, Perspective/Commentary to Redefine the Role of Pathologists Subcommittee
American Association of Medical Colleges (AAMC): Group on Graduate Research Education and Training (GREAT):
Annual Meeting Program Committee, 2010-2012, 2013-2014 Member, Faculty Mentoring Subgroup, 2011-2012 Member, Review Committee, AAMC Award for Innovation in Research Training and Education (2012) Leader, Strategic Plan, GREAT Committee Future Impact, 2012-2014 Member, Communication Committee, 2013-2018
Group on Research Advancement and Development (GRAND): Annual Meeting Program Committee, 2012-2013 Council of Faculty and Academic Societies (CFAS):
Appointed Representative, Academy of Clinical Laboratory Physicians and Scientists (ACLPS), 2013-2018
Basic Science Evaluation Expert Panel, 2013-2015 Group on Educational Affairs: UAB Research in Education Representative, 2015-2018 Group on Women in Medicine and Science UAB Representative, 2015-2018
p. 9 of 45 Robinna G. Lorenz
Committee for Creating a Physician-Scientist Training Home, 2018-present American Society for Investigative Pathology (ASIP): Councilor, 2016-2019
Representative, FASEB Science Policy Committee Member, Meritorious Award Committee, 2019-2022
American Society for Clinical Pathology: Member, ASCP Effective Test Utilization Advisory Board, 2018-present American Physician Scientist Association (APSA): Member, Board of Directors, 2016-2019 Council of the Association of Pathology Chairs: Pathology Roundtable
ACLPS Representative, 2012-2014 Chair, PhD Workforce Task Force, 2014-2018 Physician Scientist Working Group of the Research Committee Member, 2017-present Research Committee Member, 2019-present
American Association of Immunologists:
Block Co-chair for Mucosal and Regional Immunology, AAI 2005, AAI 2006 Program Committee, July 2005-June 2008 Awards Committee, 2013-2016 (Chair, 2015-2016)
MST Program Director Representative to the All TWD Advisory Group (Training, Workforce, Development and Diversity), NIH NIGMS, 2012-2015 Building the Next Generation of Academic Physicians (BNGAP)
Organizer, 2017 Academic Medicine Regional Conference, February 2017, Birmingham, AL The Histochemical Society: Publications Committee, 2013-present (Chair 2015-present)
Councilor, 2014-2020
National Board of Medical Examiners (NBME): Advisory Committee for Medical School Programs AAMC GREAT/CFAS representative, 2014-2018 FASEB Science Policy Committee: ASIP Representative, 2015-current American Cancer Society:
Ad-hoc member, Molecular and Cell Biology of Cancer Review Committee, 2002-2005
p. 10 of 45 Robinna G. Lorenz
Member, Molecular and Cell Biology of Cancer Review Committee, 2006-2008 Vice Chair, Microbial Pathogenesis and Cancer Review Committee, 2009 Chair, Microbial Pathogenesis and Cancer Review Committee, 2010 Member, National ACS Council for Extramural Grants, 2016-2021 Co-Chair, Review Committee, TheoryLab Collaborative Pilot Grants
Fondazione Cariplo (Miliano, Italy):
Grant Revewer, Medical-Scientist: Training and Job-Market Induction Proposals, August 2017
Clinical and Laboratory Standards Institute (formerly NCCLS):
Member, Area Committee on Immunology and Ligand Assay, 2002-2005 Vice-Chairholder, Area Committee on Immunology and Ligand Assay, 2006-2010
Crohn’s and Colitis Foundation:
Research Training Awards Committee, 2003-2005; Ad-hoc member 2010 Co-Chair, Research Training Awards Committee, 2006-2008
Member, National Scientific Advisory Committee, 2005-2008 American Gastroenterology Association:
Member, Abstract Review Committee, IMIGD Section, DDW 2002, 2005. 2006 The Eli and Edythe L. Broad Foundation:
Ad Hoc Reviewer, Inflammatory Bowel Disease Grants, April 2002, February 2013
Society for Mucosal Immunology: Membership Committee, 2006-2007 Virginia Department of Planning and Budget:
Ad Hoc Reviewer, Strategic Institutional Enhancement Program, Commonwealth Technology Research Fund, October 2001
German Research Foundation (Bonn, Germany): Grant Reviewer, Clinician Scientist Programs, July 2018 Industry 2019-2022 Member, Appointments and Promotions Review Committee (APRC),
Genentech, Inc., South San Francisco University 1994-2002 Chairman of one Division of Biology and Biomedical Sciences Thesis
Committee and a member of 8 other thesis committees, Washington University, St. Louis, MO
p. 11 of 45 Robinna G. Lorenz
1994-2002 Member of Immunology Preliminary Exam Committee, Division of
Biology and Biomedical Sciences, Washington University, St. Louis, MO 1996-2002 Immunology Program Representative, Graduate Admissions Committee,
Division of Biology and Biomedical Sciences, Washington University, St. Louis, MO
2003-2005 Laboratory Medicine Representative, Pathology Faculty Advisory
Council, University of Alabama at Birmingham, Birmingham, AL 2003-2006 Director of Admissions, Integrative Biological Sciences Graduate
Program, University of Alabama at Birmingham, Birmingham, AL 2003-2007 Member, Molecular and Cellular Pathology Graduate Program Steering
Committee, University of Alabama at Birmingham, Birmingham, AL 2004-2018 Program Director, SIBS Undergraduate Research Program, University of
Alabama at Birmingham, Birmingham, AL 2004-2014 Associate Director, Mucosal HIV and Immunobiology Center (Digestive
Diseases Research Development Center), University of Alabama at Birmingham, Birmingham, AL
2004-present Member of multiple graduate student preliminary examination committees
and thesis committees, University of Alabama at Birmingham, Birmingham, AL
2005-2014 Member, Core Leadership Team, UAB Hughes Med-Grad Fellowship
Program, University of Alabama at Birmingham, Birmingham, AL 2006-2018 Director, UAB Medical Scientist Training Program (NIH/NIGMS T32
funded), University of Alabama at Birmingham, Birmingham AL 2008-2016 Member, Graduate Biomedical Sciences (GBS) Steering and Oversight
Committee, University of Alabama at Birmingham, Birmingham AL 2008-2011 Member, Bacterial Pathogenesis Training Program Advisory Committee,
University of Alabama at Birmingham, Birmingham AL 2008-2018 Member, Immunology Graduate Program Steering Committee, University
of Alabama at Birmingham, Birmingham AL 2010-2015 Member, Graduate Biomedical Sciences (GBS) Steering and Oversight
Committee, Finance Subcommittee, University of Alabama at Birmingham, Birmingham, AL (Chair 2010-2012)
p. 12 of 45 Robinna G. Lorenz
2010-2015 Member, UAB Bookstore Advisory Committee, University of Alabama at
Birmingham, Birmingham, AL 2010-2018 Member, UAB ABIM Research Pathway Steering Committee, University
of Alabama at Birmingham, Birmingham, AL 2010-2015 Member, UAB Diabetes Obesity and Metabolism Steering Committee,
University of Alabama at Birmingham, Birmingham, AL 2010-2018 Director, Medical Student Summer Research Program (NIH/NHLBI T35
funded), University of Alabama at Birmingham, Birmingham, AL 2012-2014 Member, UAB Education Program Committee for LCME Self Assessment
Study, University of Alabama at Birmingham, Birmingham, AL 2014-2015 Chair, UAB Department of Pathology Laboratory Medicine Director
Search Committee, University of Alabama at Birmingham, Birmingham, AL
2014-2018 Program Director, Preparation for Graduate and Medical Education
(PARAdiGM), University of Alabama at Birmingham, Birmingham, AL 2014-2018 Member, UAB Department of Pathology Promotion and Tenure
Committee, University of Alabama at Birmingham, Birmingham, AL 2015-2018 Chair, Lab Diagnosis Test Utilization Committee, University of Alabama
at Birmingham, Birmingham, AL 2015-2017 Member, Medical Education Committee Certificate Task Force,
University of Alabama at Birmingham, Birmingham, AL 2015-2016 Member and Alternate Co-Chair, Dermatology Chair Search Committee,
University of Alabama at Birmingham, Birmingham, AL 2016-2018 Member, UAB Department of Medical Education Promotion and Tenure
Committee, University of Alabama at Birmingham, Birmingham, AL 2016-2018 Member, CCTS Training Academy Partner Network Steering Committee,
University of Alabama at Birmingham, Birmingham, AL 2016-2018 Chair, UAB Department of Pathology Promotions and Tenure Committee,
University of Alabama at Birmingham, Birmingham, AL 2016-2018 Member, Internal Advisory Committee, Research Training Programs of
the Immunologic Diseases and Basic Immunology T32 and the Training
p. 13 of 45 Robinna G. Lorenz
Program in Rheumatic and Musculoskeletal Diseases Research T32, University of Alabama at Birmingham, Birmingham, AL
2016-2018 Member, Graduate Biomedical Science Theme Director Council,
University of Alabama School of Medicine, Birmingham, AL 2017-2018 Chair, Education Committee and Member, Executive Steering Committee
for the development of a Master Plan for Space Utilization, University of Alabama School of Medicine, Birmingham, AL
2017-2018 Member, Steering and Oversight Committee for Education and Training,
Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL
2017-2018 Member, Internal Advisory Committee, UAB Center for Clinical and
Translational Science (CCTS), University of Alabama at Birmingham, Birmingham, AL
2017-2018 Member, Mental Health and Wellness Council, UAB Graduate
Biomedical Sciences, University of Alabama at Birmingham, Birmingham, AL
2018 Co-Director, CCTS NRSA Training Program (TL1), University of
Alabama at Birmingham, Birmingham, AL Community 2004-2010 Member, Birmingham Figure Skating Club Board of Directors 2005-2008 Test Chair, Birmingham Figure Skating Club 2006 Chair of USFS Officials Committee, 2007 Midwestern Sectional
Championships, Unites States Figure Skating, Birmingham, AL 2006-2008 Vestavia Hills Math Tournament Committee, Vestavia Hills, AL 2008-2009 Vice-President, Vestavia Hills Math Team Parents Association, Vestavia
Hills, AL
2008-2009 President, Birmingham Figure Skating Club
2009-2010 Treasurer, Birmingham Figure Skating Club 2009-2010 President, Vestavia Hills Math Team Parents Association, Vestavia Hills,
AL
2010 Competition Chair, Magic City Ice Classic, Birmingham Figure Skating Club, Pelham, AL
p. 14 of 45 Robinna G. Lorenz
2012 Competition Co-Chair, Blades in Bama, Birmingham Figure Skating Club, Pelham, AL
2017-2018 Alabama Chair, Stanford Office of Undergraduate Admission’s Alumni Volunteer Program
EDITORIAL BOARD MEMBERSHIPS: 06/1994-present Ad Hoc reviewer for American Journal of Clinical Pathology, American
Journal of Physiology – Gastrointestinal and Liver Physiology, Blood, Cellular Immunology, Clinical Chemistry, Clinical and Diagnostic Laboratory Immunology, Clinical Gastroenterology & Hepatology, Gastroenterology, Inflammatory Bowel Disease, Journal of Experimental Medicine, Journal of Histochemistry and Cytochemistry, Journal of Immunology, Proceedings of the National Academy of Science, Journal of Obesity
07/2003-06/2015 Editorial Board, American Journal of Physiology – Gastrointestinal and Liver
Physiology 2003-2010 Editorial Board, World Journal of Gastroenterology 04/2004-06/2008 Associate Editor, The Journal of Immunology 08/2005-present Editorial Board, The Journal of Histochemistry and Cytochemistry 05/2009-present Editorial Board, Pathology and Laboratory Medicine International 01/2013-12/2017 Senior Assistant Editor, The American Journal of Pathology 07/2019-present Editorial Board, Academic Pathology MAJOR RESEARCH INTERESTS: The focus of research in my laboratory has been the study of the cellular components of the mucosal immune system and their interactions with the gastrointestinal epithelium and luminal contents. We have investigated the cellular immune response to Helicobacter in a mouse model of gastric infection, inflammation and adenocarcinoma. A second focus has been on the study of intestinal epithelial barrier function in the development of inflammatory bowel disease. We have extended this focus to investigating the interrelationship between the mucosal immune response and the development of autoimmune diseases such as type 1 diabetes. TEACHING EXPERIENCE: COURSES:
p. 15 of 45 Robinna G. Lorenz
2016-2017 Co-Course Director, GBS 746-01K Mastering the Art of Reproducible Science,
Graduate Biomedical Sciences, University of Alabama at Birmingham, Birmingham, AL
Program, University of Alabama at Birmingham, Birmingham, AL 2006-2018 Course Director, HMG 702, Phenotyping Human Disease, Hughes Med-Grad
Fellowship Graduate Course, University of Alabama at Birmingham, Birmingham, AL
2000-2002 Co-Course Director for Foundations in Immunology, Division of Biology and
Biomedical Sciences, Washington University, St. Louis, MO 1999 Temporary Course Director for Undergraduate Immunology, Washington
University, St. Louis, MO 1997-2000 Co-Course Director for Advanced Topics in Immunology, Division of Biology
and Biomedical Sciences, Washington University, St. Louis, MO LECTURES: 2012 Lecturer in Translating Science: Molecules to Man (Science and Technology
Honors Course), University of Alabama School of Medicine, Birmingham, AL (Helicobacter Infection, Inflammation and Gastrointestinal Cancer)
2012-2018 Lecturer in GI, Endocrine, and Immune System (GBS 752), University of
Alabama School of Medicine, Birmingham, AL (Mucosal Immunology) 2008-2010 Lecturer in Gastrointestinal Module, University of Alabama School of Medicine,
Birmingham, AL (Gastric Neoplasia)
p. 16 of 45 Robinna G. Lorenz
2006-2018 Lecturer in Dental and Optometry Microbiology, University of Alabama at
Birmingham, Birmingham, AL (Oral and Mucosal Immunology) 2005-2010 Lecturer in Dental General Pathology Graduate Course, University of Alabama at
Birmingham, Birmingham, AL (Immunopathology) 2005-2018 Lecturer in Immunology (CMB6/now GBS 740), Graduate program in Cellular
and Molecular Biology/Immunology, University of Alabama at Birmingham, Birmingham, AL (Mucosal Immunology)
2005-2012 Faculty Evaluator for Pathology Research Data Analysis and Presentation (PAT
704), Graduate Program in Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL
2004-2011 Lecturer in Bacterial Pathogenesis (CMB7, Module 4), Graduate Program in
Cellular and Molecular Biology, University of Alabama at Birmingham, Birmingham, AL (Helicobacter pathogenesis)
2004-2011 Lecturer in Pathophysiology and Pharmacology of Disease (PAT 701), Graduate
Program in Molecular and Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL (Type I Diabetes Lecture and student presentations)
2004-2011 Lecturer in Dental Clinical Pathology Graudate Course, University of Alabama at
Birmingham, Birmingham, AL (Hepatitis and AIDS) 2003-2006 Lecturer in Biology of Disease (PAT 700), Graduate Program in Molecular and
Cellular Pathology, University of Alabama at Birmingham, Birmingham, AL (Immunopathology Lectures and student discussions)
2002-2007 Lecturer in Medical General Pathology, University of Alabama at Birmingham
School of Medicine, Birmingham, AL (Immunopathology Lectures and Laboratory)
2002-2018 Didactic sessions on Clinical Laboratory Immunology, Clinical Pathology
Residency, University of Alabama Health System, Birmingham, AL 1996-2002 Laboratory and Discussion Section Leader for Medical Immunology, Washington
University School of Medicine, St. Louis, MO 1995-2002 Lecturer in Foundations in Immunology, Division of Biology and Biomedical
Sciences, Washington University, St. Louis, MO (2 Mucosal Immunology Lectures)
p. 17 of 45 Robinna G. Lorenz
1995-2002 Laboratory sessions on Clinical Laboratory Immunology, Rheumatology and Allergy and Immunology Residency’s, Barnes-Jewish Hospital, St. Louis, MO
1995-2002 Laboratory and Didactic sessions on Clinical Laboratory Immunology, Fourth
Year Elective, Washington University School of Medicine, St. Louis, MO 1994-2002 Laboratory and Didactic sessions on Clinical Laboratory Immunology,
Laboratory Medicine Residency, Barnes-Jewish Hospital, St. Louis, MO 1998-1999 Lecturer in Undergraduate Immunology, Washington University, St. Louis, MO
(Mucosal Immunology and Innate Immunity Lectures) 1995-1997 Section Leader for Ethics and Research Science, Division of Biology and
Biomedical Sciences, Washington University, St. Louis, MO 1995-1998 Lecturer in Molecular Mechanisms of Disease, Division of Biology and
Biomedical Sciences, Washington University, St. Louis, MO (2 Inflammatory Bowel Disease Lectures)
Clinical Chemist, Bellevue Hospital, New York, NY) 1995 Michelle Kaplan, Undergraduate Bio 500 Honors Student 1996-2001 Rodney D. Newberry, M.D., Postdoctoral Fellow (Current Position, Associate
Professor, Department of Medicine, Washington University School of Medicine, St. Louis, MO)
1996-2001 Steven M. Martin, B.S., Graduate Student (Immunology) (Current Position,
Senior Scientist, Sequoia Sciences, St. Louis, MO) 1998-2001 Joel Schilling, B.S., MD/PhD Student (Microbiology, secondary advisor) (Current
Position, Instructor in Medicine, Cardiovascular Division, Washington University, St. Louis, MO)
1996-1997 Blair Madison, Howard Hughes Undergraduate Research Fellow (Current
Position, Assistant Professor, Department of Gastroenterology, Washington University School of Medicine, St. Louis, MO)
1997 David Blair, High School Young Scientist Program 2000 Shinkai Hakimi, Undergraduate Bio 500 Honors Student (MD and
Residency/Fellowship (Internal Medicine/Pulmonology) University of Iowa; Pulmonologist, Iowa City, IA)
p. 18 of 45 Robinna G. Lorenz
2000 Kwame Adu-Wusu, Prefreshman Summer Scholars Program in Biology (Medical Student, Case Western Reserve)
2000-2002 Vance J. McCracken, Ph.D., Postdoctoral Fellow (Current Position, Assistant
Professor, Department of Biological Sciences, Southern Illinois University, Edwardsville, IL)
2003-2005 Camalla Kimbrough, High School Scientist Program and Crohn’s and Colitis Student Research Fellow (JD, Tulane University Law School, New Orleans, LA;
Associate at Baker, Donelson, Bearman, Caldwell & Berkowitz, PC, New Orleans, LA)
2004-2011 Reed A. Dimmitt, M.D., Post-Graduate Student (Associate Professor, Pediatrics
and Division Director, Pediatric Gastroenterology, Children’s Hospital of Alabama)
2004-2008 Julia M. Schmitz, Graduate Student (Microbiology) (Current Position, Assistant
Professor of Biology, Piedmont College, Piedmont, GA) 2005-2009 Elizabeth M. Staley, Graduate Student (Microbiology) (Current Position,
Assistant Professor of Laboratory Medicine, University of Washington, Seattle, WA)
2006 Dale S. Carter, SIBS Undergraduate Research Program (MD from University of
Alabama School of Medicine, Birmingham, AL; current position Anesthesiology Resident, Medical College of South Carolina, Charleston, SC)
2007-2008 Anna Seay, Undergraduate Student, University of Alabama at Birmingham
(Current position, Medical Student, University of South Alabama, Mobile, AL) 2007-2010 Carolyn Durham, Graduate Student (Pathology) (Current Position, Chief
Operations Officer, Renovion, Chapel Hill, NC) 2007-2008 Matthew Hull, Undergraduate Student, Birmingham Southern College,
Birmingham, AL (Current Position, Anesthesiology Resident, University of Alabama at Birmingham, Birmingham, AL)
2008-2012 Scott Tanner, Graduate Student (Pathology)(Current Position, Assistant Professor,
Department of Biological, Earth, and Physical Sciences, Limestone College, Gaffney, SC)
6/08-8/08 Vanisha Yarbrough, NIDDK STEP-UP Program, Undergrad Student, 6/09-8/09 Harvard University, Boston, MA (Current Position, Medical Student, University of Michigan, Ann Arbor, MI)
p. 19 of 45 Robinna G. Lorenz
2008-2009 Nizamjan Rustamov, Undergraduate Student, University of Alabama at Birmingham (Current Position, Pharmacy Student, Auburn University, Auburn, AL)
6/09-8/09 Rebecca Schuster, UAB PREP Program, Undergraduate Student, University of
North Carolina at Chapel Hill. NC (Current Position, Teach For America, 6th/7th Grade Science, Dallas, TX)
Student, Vanderbilt University, Nashville, TN) 2012-2018 Colin Martin, M.D., Associate Professor, Pediatric Surgery, Children’s Hospital
of Alabama 2013-2014 Stephanie Hill, Postbaccalaureate Student (PREP) (Current Position, Medical
Students, Medical College of Georgia - Georgia Regents University, Augusta, GA)
2013-2016 Marguerite (Bree) Little, Crohn’s and Colitis Student Research Fellow,
Undergraduate student, University of Montevallo (Current Position, Graduate Student, University of North Carolina, Chapel Hill, NC)
2018-2020 Keri M. Kemp, PhD, UAB IRADCA-MERIT Postdoctoral Scholar, University of
Alabama at Birmingham, Birmingham, AL MAJOR LECTURES AND VISITING PROFESSORSHIPS: “Oral Tolerance: An alternative immunotherapy for the future” 1996 Annual Meeting of the Academy of Clinical Laboratory Physicians and Scientists, St. Louis, MO (June 1996) Invited Seminar Speaker, Department of Laboratory Medicine, Yale University School of Medicine (October 2000) Invited Seminar Speaker, Department of Pathology, Emory University School of Medicine (January 2001)
p. 20 of 45 Robinna G. Lorenz
Invited Senior Faculty Session Chair, IBD Research: Junior Faculty Symposium, Chicago, IL (January 2002). Invited Session Chair and Speaker, FASEB Summer Research Conference on Microbial Pathogenesis: Mechanisms of Infectious Diseases, Snowmass, CO (August 2002). Invited Speaker, Microbial-Mucosal Interactions, Center for the Study of Inflammatory Bowel Disease, Boston, MA (November 2002). Invited Speaker, Oral Tolerance: Mechanisms and Applications, New York Academy of Sciences, New York, NY (October 2003) Invited Speaker, Bacterial-Host Interactions in Gut Inflammation, American Physiological Society, Snowmass, CO (September 2004) Invited Participant, National Cancer Institute Workshop on Mucosal Immunosurveillance, Inflammation and Cancer, Bethesda, MD (April 2005) Invited Session Chair, Immunoregulation at Mucosal Surfaces, Experimental Biology / American Association of Immunologists, San Diego, CA (April 2005). Invited Senior Faculty Reviewer, IBD Research: Junior Faculty Symposium, Baltimore, MD (May 2005, 2006). Invited Session Chair, Basic Mucosal Immunology of IBD, Digestive Disease Week, Chicago, IL (May 2005). Invited Keynote Speaker, Medical Student Research Day, University of Alabama at Birmingham, Birmingham, AL (November 2005). Invited Speaker, Atlantic Digestive Diseases Centers Conference, Charlottesville,VA (January 2006) Invited Seminar Speaker, Department of Pharmacology and Toxicology, The University of Texas Medical Branch (January 2006) Invited Seminar Speaker, UCI Center for Immunology and UCI Cancer Research Institute, University of California, Irvine (January 2006) Award Acceptance Speech, Ellis Benson Award, ACLPS Meeting, Chicago, IL (June 2006) Invited Speaker, UAB Comprehensive Cancer Research Retreat, Birmingham, AL (October 2008) Invited Panel Member, Women Physician-Scientists, GREAT Group MD-PhD Section Annual Meeting, American Association of Medical Colleges (July 2009)
p. 21 of 45 Robinna G. Lorenz
Invited Speaker and Panel Member, Clinical Investigator Student Trainee (CIST) Forum, Howard Hughes Medical Institute, Washington DC (November 2009) Invited Speaker, Washington University in St. Louis Medical Scientist Training Program 40th Anniversary Symposium, St. Louis, MO (April 2010) Invited Speaker and Discussion Leader, Residency Choices for Physician Scientists, American Physician Scientist Association Annual Meeting, Chicago, IL (April 2010) Invited Speaker, UAB Diabetes Day, Birmingham, AL (May 2010) Invited Speaker, Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, IL (October 2010) Invited Speaker and Panel Member, American Physician Scientists Association Southeast Medical Scientist Symposium, Birmingham, AL (October 2010) Invited Speaker and Panel Member, Barriers to Progress: Retaining Trainees In Your Program, GREAT Group MD-PhD Section Annual Meeting, American Association of Medical Colleges (October 2010) Keynote Speaker, American Physician Scientists Association 2010 Midwest Regional Meeting, Columbus, OH (October 2010) Invited Speaker and Panel Member, NIH Graduate and Professional School Fair, Washington DC (July 2011, July 2012, July 2014)(webcast: http://videocast.nih.gov/summary.asp?Live=11386) Invited Speaker and Panel Member, American Society for Biochemistry and Molecular Biology Annual Meeting, “Will Combined MD-PhD Training Make Me Twice as Successful?”, San Diego, CA (April 2012) Keynote Speaker, Thomas Jefferson University MD/PhD Program Retreat, Philadelphia, PA (October 2012) Invited Speaker, Minority Student Medical Career Awareness Workshop, AAMC National Meeting, “MD-PhD Careers”, San Francisco, CA (November 2012) Invited Speaker, Department of Pathology, Geisel School of Medicine, Dartmouth College, Hanover, NH (June 2013) Session Organizer and Discussant, AAMC Group on Research Advancement and Development (GRAND) Annual Meeting, “Physician Scientists in Academic Medical Centers: Models for Funding and Career Success”, Washington DC (June 2013) Invited Speaker and Panel Member, GREAT Group Annual Meeting, American Association of Medical Colleges, Atlanta, GA (October 2013)
p. 22 of 45 Robinna G. Lorenz
Invited Keynote Speaker, Pennsylvania State College of Medicine MD/PhD Retreat, University Park, PA (March 2014) Invited Workshop Speaker, American Society for Biochemistry and Molecular Biology Annual Meeting, “ASBMS Exploring Careers after College”, San Diego, CA (April 2014) Invited Session Co-Chair, ASIP Minisymposium “Cancer Inflammation, Immunity and Angiogenesis”, Experimental Biology 2014, San Diego, CA (April 2014) Invited Speaker, Association of Pathology Chairs 2014 Annual Meeting, “The Physician-Scientist Pathway in Pathology” and “The workforce in Pathology and Laboratory Medicine”, Boston, MA (July 2014) Featured Speaker, American Physician Scientists Interactive Session (webinar), July 2014 Invited Speaker, Department of Microbiology and Center for Immunology, Iowa College of Medicine, Iowa City, Iowa (August 2014) Invited Discussion Leader, American Association of Immunologists Annual Meeting (Immunology 2015), “Careers in Science – The Physician Scientist: balancing clinical and research duties”, New Orleans, LA (May 2015) Invited Workshop Leader, Howard Hughes Medical Institute Medical Fellows Meeting, “Research Residencies”, Washington, DC (May 2015) Invited Featured Guest, NEJM Group Open Forum “Physician-Scientist Training: Current Options and Future Changes”, https://medstro.com/groups/nejm-group-open-forum/discussions/163 (July 2015) Session Organizer and Presenter, 2015 National Association of MD-PhD Programs Annual Meeting, “Preparing a T32 Application” and “Postgraduate Training for MD-PhDs: Optimizing the Path to Independence Part I: Research Residencies”, Keystone, CO (July 2015). Invited Speaker, Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT (March 2016) Invited Workshop Participant, American Society for Biochemistry and Molecular Biology Annual Meeting, “ASBMS Exploring Careers after College”, San Diego, CA (April 2016) Invited Speaker, Association of Pathology Chairs 2016 Annual Meeting, “Fostering the Development of the Physician-Scientist Pathway”, San Diego, CA (July 2016) Invited Panel Member, Building a Physician Scientist Community, 2016 AAMC GREAT and GRAND Group Annual Meeting, Chicago, IL (September 2016)
p. 23 of 45 Robinna G. Lorenz
Invited Speaker, “Careers in Medicine and Biomedical Science”, Department of Natural Sciences, Piedmont College, Demorest, GA (February 2017) Invited Speaker, “Research Residencies and Physician-Investigator Development”, Translational Science 2017, Washington, DC (April 2017) Session Organizer and Moderator, XVIIth Annual Workshop on Graduate Education in Pathology: PhD Clinical Laboratory Scientist Workforce (Sponsored by the ASIP Education Committee), Experimental Biology 2017, Chicago, IL (April 2017) Invited Plenary Session Moderator, NIH Program (T32) and Individual Fellowships (F30/F31), 2017 AAMC GREAT MD-PhD Section Annual Meeting, Washington DC (July 2017) Invited Speaker, “Careers in Medicine and Biomedical Science”, NSF/iMASS Program, Lee University, Cleveland, TN (September 2017) Invited Keynote Speaker, American Physician Scientist Northeast Regional Meeting, Rochester, NY (October 2017) Invited Speaker, “Careers in Medicine and Biomedical Science”, Science Club, Judson College, Marion, AL (February 2018) Invited Speaker, “Physician Scientist Training Programs (PSTP): Identifying Best Practices and Improvement Strategies”, AAMC Continuum Connections: A Joint Meeting of the GSA, GRA, OSR, and ORR, Orlando, FL (April 2018) Invited Workshop Participant, NIH/NHLBI: Training Strategies to Enhance the Diversity of the Biomedical Workforce, Bethesda, MD (May 2018) Invited Webinar Speaker, Association of Pathology Chairs Webinar Series, “Pathology Workforce: Don’t Forget About the PhD’s!” June 27, 2018. Invited Breakout Session Leader, 2018 National MD/PhD Student Conference, Keystone, CO, July 2018. Invited Keynote Speaker, South Eastern Medical Scientist Symposium (SEMSS), Birmingham, AL (October 2019) Invited Speaker, Washington University Medical Scientist Training Program 50th Anniversiary Celebration, Saint Louis, MO (May 2020) PATENTS: Barchas JD, Weber E, Evans CJ, Chang JK, Lorenz RG, Roth KA: Gastrin releasing peptide-like peptides. US Patent Number: 4,613,586 Issued: September 23, 1986.
p. 24 of 45 Robinna G. Lorenz
Roth KA and Lorenz R: Method for localization and quantitation of a substance in a biological sample. US Patent Number: 5,902,727 Issued: May 11, 1999. WIPO Number: 1998010290 Issued: March 13, 1998. EPO Number: 1023604 Issued: August 2, 2000. GRANT SUPPORT: Current Molecular Mechanisms of Early Life Stress and Risk of Inflammatory Bowel Disease Principal Investigator: Jennifer Pollock, PhD Consultant (previously PI): Robinna G. Lorenz, M.D., Ph.D. Agency: Crohn’s and Colitis Foundation Period: January 2018 – December 2020 The overall goal of this project is to elucidate mechanistic pathways sensitive to early life stress in mice and humans leading to enhanced IBD risk. Past "Molecular and Immunologic Investigations of Intestinal M Cells" Principal Investigator: Robinna Lorenz, MD, PhD Agency: Charles E. Culpeper Foundation Type: Scholarship in Medical Science Period: July 1, 1995 to June 30, 1998 The major goals of this project were to determine the cells and or factors involved in the generation of M cells from intestinal crypt stem cells; to identify M cell specific proteins and generate M cell specific antibodies. "Genetic Mapping of Helicobacter Host Susceptibility Loci" Principal Investigator: Robinna Lorenz, MD, PhD Agency: Howard Hughes Medical Institute Type: Institutional Period: January 1, 1998 to December 31, 1999 The major goal of this pilot project was to determine the genetic basis of the non-MHC component of resistance to gastric pathology after H. felis infection that is associated with the BALB/c background.
“Transgenic Models of Autoimmune Gastritis” Principal Investigator: Robinna Lorenz, MD, PhD Agency: NIH/NIDDK Type: 5 R21 (DK57926-02) Period: September 30, 1999 to August 31, 2002
The major goal of this grant was to generate a novel transgenic mouse model of autoimmune gastritis to define the cellular and molecular mechanisms of autoimmune gastritis. “Autoimmune Gastritis Initiated by Helicobacter Infection”
Principal Investigator: Robinna Lorenz, MD, PhD Agency: NIH/NIDDKD Type: 5 R21 (DK57936-02) Period: September 30, 1999 to November 30, 2002
p. 25 of 45 Robinna G. Lorenz
The major goals of this grant were to develop a lymphocyte transfer model of Helicobacter-associated gastric pathology and to determine the role of self-antigen mimicry in this model of disease.
“Celiac Disease in Osteoporosis” Principal Investigator: William Stenson, MD Agency: NIH/NIDDK Type: 1 RO1 (DK5789-01) Period: June 15, 2000 to May 31, 2004
The specific goals of this grant were to define the prevalence of celiac disease in a population of patients with osteoporosis and to compare their reponse to treatment.
“The Role of Helicobacter Gastritis in Gastric Carcinoma” Principal Investigator: Robinna Lorenz, MD, PhD Agency: American Cancer Society Type: RPG-99-086-MBC / RSG MBC-103892 Period: January 1 1999 to June 30, 2006
The major goals of this project were to define the innate immune responses in Helicobacter-associated CD4+ T-cell mediated gastric dysplasia and the associated gastric adenocarcinoma formation. “Summer in Biomedical Sciences (SIBS) Undergraduate Research Program” Principal Investigator: Robinna Lorenz, MD, PhD Agency: UA Health Services Foundation Type: Medical Education Initiative Period March 1, 2005-February 28, 2009 This grant funds a program that provides an opportunity for undergraduate students to carry out independent research projects under the guidance of UAB faculty mentors. “T Cell Initiated Gastric Pathology” Principal Investigator: Robinna Lorenz, MD, PhD Agency: NIH/NIDDK Type: RO1 (DK059911) Period January 10, 2003-December 31, 2009 (no cost extension) The major goals of this grant focus on the characterization of the antigen recognition requirements of the CD4+ T-cell critical for the development of Helicobacter-associated gastric pathology and the determination of the role of secreted or cell surface products in the generation of Helicobacter-associated gastric epithelial pathology. “Modulation of Allergic Asthma by Gastric Helicobacter Infection” Principal Investigator: Robinna G. Lorenz, M.D., Ph.D. Agency: Sandler Program for Asthma Research Type: Early Excellence Award (06-0167) Period: July 1, 2006 – June 30, 2010 The goal of this grant is to directly test the association between gastrointestinal infections and decreased asthma incidence through the use of a murine model of gastric helicobacter colonization and inflammation. “Innate and Adaptive Microbial Immunity in IBD” Principal Investigator of Program Project: Charles O. Elson, MD Agency: NIH/NIDDK
p. 26 of 45 Robinna G. Lorenz
Type: P01 (DK071161) Period August 10, 2005 – July 31, 2012 Project 2: “Epithelial and Innate Sensors of the Microbiota in IBD” Principal Investigator of Project 2: Robinna G. Lorenz, MD, PhD The major goals of this grant focus on the role of intestinal epithelial and immune P-glycoprotein in the development of inflammatory bowel disease. “The Gastrointestinal Ecosystem and Risk of Diabetes Development” Principal Investigator: Robinna G. Lorenz, M.D., Ph.D. Agency: Juvenile Diabetes Research Foundation Type: Research Grant (36-2008-930) Period: September 1, 2008-August 31, 2012 The goal of this grant is to determine the interrelationship between the GI microbiota, the intestinal immune response, and the risk of type-1 diabetes development in the NOD mouse model. “Mucosal HIV and Immunobiology Center” Principal Investigator: Phillip D. Smith, MD Agency: NIH/NIDDK Type: R24 (DK064400) Period June 1, 2003-May 31, 2013 This grant is to fund a Digestive Diseases Research Development Center. I am Co-Director of the Center and Director of Core 2, the Cell and Molecular Pathology Core. Altered Handling and Sensing of Xenobiotics in Inflammatory Bowel Disease Principal Investigator: Robinna G. Lorenz, M.D., Ph.D. Agency: Crohn’s and Colitis Foundation of America Type: Senior Research Award (26971) Period: January 1, 2012 – December 31, 2014 The goal of this grant is to determine if environmental factors, such as cigarette smoke and microbial components, can be pumped by P-gp and alter the incidence of IBD in a P-gp deficient mouse model. Dietary Influences in Colorectal Cancer: Role of Xenobiotic Pumps and Sensors Principal Investigator: Robinna G. Lorenz, M.D., Ph.D. Agency: UAB Comprehensive Cancer Center Richard A. Elkus Eminent Scholars Program in GI Oncology Research Type: Research Grant Period: September 1, 2012-August 31, 2014 The goal of this grant is to determine the interrelationship between the GI microbiota, dietary influences and the handling of dietary xenobiotics. Interactions Between AhR Ligands and the Gut Microbiota in Murine Arthritis Principal Investigator: Matthew Stoll (Co-investigator: Robinna G. Lorenz, MD, PhD) Agency: NIH/NIEHS Type: R21 (ES024413) Period: August 1, 2014-July 31, 2016 This grant investigates whether AhR ligands contribute to spondyloarthritis in a mouse model of the disease. The Use of Team Learning Activities to Maintain Clinical Competencies and Foster New Clinical Knowledge in Dual Degree MD/PhD Students.
p. 27 of 45 Robinna G. Lorenz
Principal Investigator: Robinna G. Lorenz, M.D., Ph.D. Agency: UAB Center for Teaching and Learning (CTL) Type: Teaching Innovation and Development Award Period: January 1, 2014 – December 31, 2015 The goal of this grant is to determine if a three-pronged curriculum can maintain and mature clinical skills of MD/PhD student in their graduate years. Mastering the Art of Reproducible Science (Supplement to T32 – Predoctoral Training in Cell and Molecular Biology) Principal Investigator: Bradley Yoder (Co-investigator: Robinna G. Lorenz, MD, PhD) Agency: NIH/NIGMS Type: T32 (GM008111-28S1) Period: July 1, 2015-June 30, 2016 This grant is to develop a course to teach reproducible science to our PhD and MD/PhD students. The Use of Team Learning Activities to Maintain Clinical Competencies and Foster New Clinical Knowledge in Dual Degree MD/PhD Students. Principal Investigator: Robinna G. Lorenz, M.D., Ph.D. Agency: UAB Center for Teaching and Learning (CTL) Type: Teaching Innovation and Development Supplemental Award Period: September 2017 – August 2018 The goal of this grant is to continue our studies to determine if a three-pronged curriculum can maintain and mature clinical skills of MD/PhD student in their graduate years. UAB Center for Clinical and Translational Science (CCTS) Principal Investigator: Robert Kimberly, M.D. Agency: NIH/NCATS Type: UL1 (TR001417) Period: August 18, 2015-March 31, 2019 The vision of the Center for Clinical and Translational Science (CCTS) Hub is to reduce health disparities in diseases disproportionately represented within the Deep South as we accelerate discovery to improve human health. Dr. Lorenz serves as a Co-Director of the TL1 Training Programs, an advisor on the Training and Career Development Steering Committee and a member of the CCTS Hub Advisory Team. Preparation for Graduate and Medical Education (PreGAME) Program (now known as the “PARAdiGM” Program) Principal Investigator: Robinna G. Lorenz, M.D., Ph.D. Agency: NIH/NHLBI Type: R25 (HL120883) Period: April 1, 2014 – March 31, 2019 The goal of this grant is to expose undergraduate students from groups underrepresented in medicine to scientific research and clinicians who practice at academic medical centers. The ultimate goal is to encourage these students to pursue careers as physician-scientists. Medical Scientist Training Program Principal Investigator: Robinna G. Lorenz, M.D., Ph.D. (transferred PI in November 2018) Agency: NIH/NIGMS Type: T32 (GM008361) Period: July 1, 1992-June 30, 2020
p. 28 of 45 Robinna G. Lorenz
The goal of this grant is to provide training leading to both the MD and the PhD degree with a rigorous academic program and supportive atmosphere to outstanding students from across the country. Southeastern Medical Scientist Symposium Principal Investigator: Robinna G. Lorenz, M.D., Ph.D. (transferred PI in March 2019) Agency: NIH/NIGMS Type: R13 (GM109532) Period: May 1, 2014-January 31, 2022 This fully student-organized symposium seeks to foster connections between the MD/PhD students at multiple institutions across the Southeast, exposing students to trends, challenges, and opportunities inherent in careers of academic physicians. Short Term Training in Health Professional Schools” Principal Investigator: Robinna G. Lorenz, M.D., Ph.D. (transferred PI in March 2019) Agency: NIH/NHLBI Type: T35 (HL007473) Period; May 1, 1991 – April 30, 2023 The goal of this grant is to introduce medical and dental students to the concept of scientific research. BIBLIOGRAPHY: MANUSCRIPTS: Peer-Reviewed Publications (ORCID 0000-0002-2514-9819) (http://www.ncbi.nlm.nih.gov/myncbi/browse/collection/40187261/?sort=date&direction=ascending) 1. Roth KA, McIntire SL, Lorenz RG, and Barchas JD: Hypothalamic catecholamine changes
under acute stress occur independently of nicotinic stimulation. Neurosci. Lett. 1982;28:47-50. 2. Evans CJ, Lorenz RG, Weber E, and Barchas JD: Variants of alpha-melanocyte stimulating
hormone in rat brain and pituitary: Evidence that acetylated a-MSH exists only in the intermediate lobe of pituitary. Biochem. Biophys. Res. Commun. 1982;106:910-919.
3. Roth KA, Evans CJ, Lorenz RG, Weber E, Barchas JD, and Chang JK: Identification of gastrin
releasing peptide-related substances in guinea pig and rat brain. Biochem. Biophys. Res. Commun. 1983;112:528-536.
4. Austen BM, Lorenz R, Spitz M, and Thorpe R: Elucidation of the antigenic determinant in
lipotropin for two monoclonal antibodies. Biochem. Biophys. Res. Commun. 1983;116:527-533. 5. Lorenz RG, Saper CB, Wong DL, Ciaranello RD, and Loewy AD: Co-localization of substance
P- and phenylethanolamine-N-methyl-transferase-like immunoreactivity in neurons of
p. 29 of 45 Robinna G. Lorenz
ventrolateral medulla that project to the spinal cord: Potential role in control of vasomotor tone. Neurosci. Lett. 1985;55:255-260.
6. Lorenz RG, Evans CJ, and Barchas JD: Effects of dehydration on pro-dynorphin derived
peptides in the neuro-intermediate lobe of the rat pituitary. Life Sci. 1985;37:1523-1528. 7. Lorenz RG, Tyler AN, Faull KF, Makk G, Barchas JD, and Evans CJ: Characterization of
endorphins from the pituitary of the spiny dogfish Squalus acanthias. Peptides 1986;7:119-126. 8. Roth KA, Lorenz RG, McKeel DW, Leykam J, Barchas JD, and Tyler AN: Methionine-
enkephalin and thyrotropin-stimulating hormone are intimately related in the human anterior pituitary. J. Clin. Endocrinol. Metab. 1988;66:804-810.
9. Lorenz RG, and Allen PM: Direct evidence for functional self-protein/Ia-molecule complexes in
vivo. Proc. Natl. Acad. Sci. USA 1988;85:5220-5223. 10. Lorenz RG, Tyler AN, and Allen PM: T cell recognition of bovine ribonuclease self/non-self
discrimination at the level of binding to the I-Ak molecule. J. Immunol. 1988;141:4124-4128. 11. Lorenz RG, and Allen PM: Thymic cortical epithelial cells can present self antigens in vivo.
Nature 1989;337:560-562. 12. Lorenz RG, Tyler AN, and Allen PM: Reconstruction of the immunogenic peptide RNase (43-
56) by identification and transfer of the critical residues into an unrelated peptide backbone. J. Exp. Med. 1989;170:203-215.
13. Roth KA, Lorenz RG, Unanue RA, and Weaver CT: Non-opiate active proenkephalin-derived
peptides are secreted by T-helper cells. FASEB J. 1989;3:2401-2407. 14. Lorenz RG, and Allen PM: Thymic cortical epithelial cells lack full capacity for antigen
presentation. Nature 1989;340:557-559. 15. Lorenz RG, Blum JS, and Allen PM: Constitutive competition by self proteins for antigen
presentation can be overcome by receptor enhanced uptake. J. Immunol. 1990;144:1600-1606. 16. Chen JS, Lorenz RG, Goldberg J, and Allen PM: Identification and characterization of a T cell-
inducing epitope of bovine ribonuclease that can be restricted by multiple class II molecules. J. Immunol. 1991;147:3672-3678.
17. Lorenz RG, Garrett N, Turk JW, Scott MA: Problems with therapeutic monitoring of
cyclosporine using silicone central venous line samples. Transplantation 1992;52:1109-1110. 18. Lorenz RG, and Gordon JI: Use of transgenic mice to study regulation of gene expression in the
parietal cell lineage of gastric units. J. Biol. Chem. 1993;268: 26559-26570.
p. 30 of 45 Robinna G. Lorenz
19. Falk P, Lorenz RG, Sharon N, and Gordon JI: The Molucella laevis lectin - a marker for cellular differentiation programs in the gastric and intestinal epithelium of developing and adult, normal and transgenic mice. Am. J. Physiol. 1995;268: G553-G567.
20. Roth KA, Brenner JW, Selznick LA, Gokden M, and Lorenz RG: Enzyme-based antigen
localization and quantitation in cell and tissue samples (Midwestern Assay). J Histochem. Cytochem. 1997;45:1629-1642.
21. Sukupolvi S, Lorenz RG, Gordon JI, Bian Z, Pfeifer JD, Normark SJ, and Rhen M: Expression
of thin aggregative fimbriae promotes interaction of Salmonella typhimurium SR-11 with mouse small intestinal epithelial cells. Infect. Immun. 1997;65:5320-5325.
22. Guruge JL, Falk PG, Lorenz RG, Dans M, Wirth HP, Blaser MJ, Berg DE, Gordon JI: Epithelial
attachment alters the outcome of Helicobacter pylori infection. PNAS 1998;95:3925-3930. 23. Syder AJ, Guruge JL, Li Q, Hu Y, Oleksiewicz CM, Lorenz RG, Karam SM, Falk PG and
Gordon JI: Helicobacter pylori attaches to neuAca2,3galb1,4 glycoconjugates produced in the stomach of transgenic mice lacking parietal cells. Mol. Cell 1999;3:263-274.
24. Thankavel K, Shah AH, Cohen MS, Ikeda T, Lorenz RG, Curtiss III R and Abraham SN:
Molecular basis for the enterocyte tropism exhibited by Salmonella typhimurium type 1 fimbriae. J. Biol. Chem 1999;274:5797-5809.
25. Roth KA, Kapadia SB, Martin SM, and Lorenz RG: Cellular immune responses are essential for
the development of Helicobacter felis associated gastric pathology. J. Immunol. 1999;163:1490-1497.
augments epithelial cytokine responses to Escherichia coli through a lipopolysaccharide-dependent mechanism. J. Immunol. 2001; 166:1148-1155.
30. McCracken VJ, and Lorenz RG: The gastrointestinal ecosystem: A precarious alliance between
epithelium, immunity, and microbiota. Cell. Microbiol. 2001;3:1-11.
p. 31 of 45 Robinna G. Lorenz
31. Newberry RD, McDonough JS, Stenson WF, and Lorenz RG: Spontaneous and continuous cycloxygenase-2 dependent prostaglandin E2 production by stromal cells in the murine small intestine lamina propria: directing the tone of the intestinal immune response. J. Immunol. 2001;166:4465-4472.
32. Martin SM, Mehta IK, Thomas ML, Yokoyama WM, and Lorenz RG: Development of
intestinal intraepithelial lymphocytes, natural killer cells, and natural killer 1.1+ T cells in CD45 deficient mice. J. Immunol. 2001; 166:6066-6073.
33. Dube PH, Revell PA, Chaplin DD, Lorenz RG, and Miller VL: A specific role for IL-1a in
inducing pathologic inflammation during bacterial infection. Proc. Natl. Acad. Sci. 2001; 98:10880-10885.
34. Newberry RD, McDonough JS and Lorenz RG: Post-gestational lymphotoxin/lymphotoxin b
receptor interactions are essential for the presence of intestinal B-lymphocytes. J. Immunol. 2002; 168:4988-4997.
35. Mysorekar IU, Lorenz RG, and Gordon JI: A gnotobiotic transgenic mouse model for studying
interactions between small intestinal enterocytes and intraepithelial lymphocytes. J. Biol. Chem. 2002; 40:37811-37819.
36. Schilling JD, Lorenz RG, and Hultgren SJ. Effect of trimethoprim-sulfamethoxazole on
recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic Escherichia coli. Infect. Immun. 2002; 70:7042-7049.
lymphoid follicle formation is inducible and dependent upon lymphotoxin-sufficient B lymphocytes, lymphotoxin b receptor, and TNF receptor I function. J. Immunol. 2003;170:5475-5482 (Cover).
40. Riehl TE, Newberry RN, Lorenz RG and Stenson WF: TNFR1 mediates the radioprotective
effects of lipopolysaccharide in the mouse intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 2004;286:G166-73.
41. Lorenz RG and Newberry RD: Isolated lymphoid follicles can function as sites for induction of
mucosal immune responses. Ann. N.Y. Acad. Sci. 2004; 1029:44-57.
p. 32 of 45 Robinna G. Lorenz
42. Stenson WF, Newberry R, Lorenz R. Baldus, C and Cicitelli, R: Increased prevalence of celiac
disease and need for routine screening among patients with osteoporosis. Arch. Int. Med. 2005; 165:393-399.
43. *McCracken VJ, *Martin SM, and Lorenz RG: The Helicobacter felis model of adoptive
transfer gastritis. Immunol. Res. 2005; 33:183-194. 44. Sandborn WJ, Stenson WF, Brynskov J, Lorenz RG, Steidle G, Robbins J, Kent JD, and Bloom,
BJ: Safety of Celecoxib in patients with ulcerative colitis in remission: A randomized, placebo-controlled pilot study. Clin. Gastro. Hep. 2006; 4:203-211.
45. Schmitz JM, McCracken VJ, Dimmitt, RA and Lorenz RG: Expression of CXCL15 (lungkine)
in murine gastrointestinal, urogenital, and endocrine organs. J. Histochem. Cytochem. 2007; 55:515-524.
46. Aprahamian CJ, Chen M, Yang Y, Lorenz RG, and Harmon CM: Two-hit rat model of short
bowel syndrome and sepsis: indendent of total parenteral nutrition, short bowel syndrome is proinflammatory and injurious to the liver. J. Ped. Surgery. 2007;42:992-997.
47. Yang Z, Harrison K, Park YA, Chaffin CH, Thigpen B, Easley PL, Smith JA, Robinson CA,
Lorenz RG, and Hardy, RW: Performance of Sebia Capillarys-II for detection and immunotyping of monoclonal paraproteins. Am. J. Clin. Path. 2007; 128:293-299.
48. Aprahamian CJ, Lorenz RG, Harmon CM and Dimmitt RA: Toll-like receptor (TLR2) is
protective of ischemia-reperfusion mediated small bowl injury in a murine model. Ped. Crit. Care Med. 2008 Jan;9(1):105-9.
49. Hsu HC, Yang P, Wang J, Wu Q, Myers R, Chen J, Guentert T, Tousson A, Stanus AL, Le TL,
Lorenz RG, Xu H, Kolls JK, Carter RH, Chaplin DD, Williams RW, and Mountz JD: Interleukin 17-producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice. Nature Immunology. 2008 Feb;9(2):166-175.
50. Harris PR, Wright S, Serrano, C, Riera F, Duarte I, Torres J, Pena A, Rollan A, Viviani P,
Guiraldes E, Schmitz JM, Lorenz RG, Novak L, Smythies LE, and Smith PD: Helicobacter pylori gastritis in Children is associated with a regulatory T cell response. Gastroenterology. 2008 Feb;134(2):491-499.
51. Staley EM, Schoeb TR and Lorenz RG: Differential Susceptibility of P-glycoprotein Deficient
Mice to Colitis Induction by Environmental Insults. Inflammatory Bowel Disease. 2009;15:684-96. PMCID: PMC2887754.
52. Schmitz JM, Durham, CG, Ho SB, and Lorenz RG: Gastric mucus alterations associated with
murine helicobacter infection. J. Histochem. Cytochem. 2009;57: 457-467. PMCID: PMC2675072.
p. 33 of 45 Robinna G. Lorenz
53. Paik JC, Howard, G, and Lorenz RG: Postgraduate Choices of Graduates from Medical Scientist Training Programs, 2004-2008. JAMA 2009;302(12):1271-1273. PMCID: PMC2778489.
54. Tatum PM, Harmon CM, Lorenz RG, and Dimmitt RA: Toll-like receptor 4 is protective
against neonatal murine ischemia-reperfusion intestinal injury. Journal of Pediatric Surgery 2010;45(6):1246-1255. PMCID: PMC2952414.
55. Dimmitt RA*, Staley EM*, Chuang G, Tanner SM, Soltau, TD, and Lorenz RG: The role of
postnatal acquisition of intestinal microbiome in the early development of immune function. Journal of Pediatric Gastroenterology & Nutrition. 2010;51(3):262-73. (*Denotes equal first authors). PMCID: PMC2932839.
56. Staley EM, Dimmitt RA, Schoeb TR, Tanner SM, Lorenz RG. Critical Role For P-
Glycoprotein Expression in Hematopoietic Cells In The FVB.Mdr1a-/- Model of Colitis. J Pediatr Gastroenterol Nutr. 2011 Dec;53(6):666-73. PMCID: PMC3658612.
of host leukocytes in peripheral immune compartments followng lethal irradiation and bone marrow reconstitution: Implication for graft versus host disease. Transplant Immunology. 2013; Mar;28(2-3):112-9. doi: 10.1016/j.trim.2013.01.001. Epub 2013 Jan 17. PMCID: PMC3640657.
62. Durham, CG, Schwiebert, LM, and Lorenz, RG: Use of the cockroach antigen model of
acute asthma to determine the immunomodulatory role of early exposure to gastrointestinal infection. Methods Mol Biol. 2013;1032:271-86. doi: 10.1007/978-1-62703-496-8_21. PMCID: PMC4097169.
63. Wolf, KJ, Daft, JG, Tanner, SM, Hartmann, R, Khafipour, E, and Lorenz, RG: Consumption of
acidic water alters the gut microbiome and decreases the risk of diabetes in NOD mice. J.
p. 34 of 45 Robinna G. Lorenz
Histochem. Cytochem. 2014; 62(4):237-250. Epub ahead of print. Jan 22, 2014. Doi: 10.1369/0022155413519650. PMCID: PMC3966285.
64. Tanner SM, Berryhill TF, Ellenburg JL, Jilling T, Cleveland DS, Lorenz RG, and Martin CA. Pathogenesis of necrotizing enterocolitis: Modeling the innage immune response (Review). Am. J. Path. 2015 Jan;185(1):4-16. doi: 10.1016/j.ajpath.2014.08.028. Epub 2014 Nov 4. PMCID: PMC4278236.
65. Daft JG, Ptacek T, Kumar R, Morrow C, and Lorenz RG. Cross-fostering immediately after
birth induces a permanent microbiota shift that is shaped by the nursing mother. Microbiome 2015 Apr 25;3:17. doi: 10.1186/s40168-015-0080-y. eCollection 2015. PMID: 25969735. PMCID: PMC4427954. (featured on the Gut Microbiota for Health website - http://gutmicrobiotaforhealth.com/s/inducing-early-sustained-shift-mouse-gut-microbiota).
66. Culbreath C, Tanner SM, Yeramilli VA, Berryhill TF, Lorenz RG, and Martin CA.
of disease pathogenesis. Commentary on “Intestinal microbiota modulates gluten-induced immunopathologoy in humanized mice”. American Journal of Pathology. 2015 Nov;185(11):2864-6. doi: 10.1016/j.ajpath.2015.09.001. Epub 2015 Sep 25. PMID: 26404513.
69. Milewicz DM, Lorenz RG, Dermody TS, and Brass LF: Rescuing the physician-scientist
workforce: the time for action is now. The Journal of Clinical Investigation. 2015 Oct 1;125(10):3742-7. doi: 10.1172/JCI84170. Epub 2015 Oct 1. PMID: 26426074. PMCID: PMC4607120.
70. Staley EM, Carruba SS, Manning M, Pham HP, Williams LA, Marques MB, Locke JE, and
Lorenz RG. Anti-blood group antibodies in intravenous immunoglobulin may complicate interpretation of antibody titers in ABOi transplantation. American Journal of Transplantation. 2016 Aug;16(8):2483-6. doi: 10.1111/ajt.13760. PMID: 26913485.
71. Cinar R, Iyer MR, Liu Z, Cao Z, Jourdan T, Erdelyi K, Godlewski G, Szanda G, Liu J, Gao M,
Mukhopadhyay B, Liow JS, Lorenz RG, Pacher P, Innis RB, Kunos G. Hybrid inhibitor of peripheral cannabinoid 1 receptors and inducible nitric oxide synthase for the treatment of liver fibrosis. JCI Insight. 2016 Jul 21;1(11). pii: e87336. PMID: 27525312. PMCID:PMC4979564.
72. Williams LA III, Lorenz RG, Tahir A, Pham HP, and Marques MB. High percentage of
evanescent red cell antibodies in patients with sickle cell disease highlights need for a national antibody database. South Med J. 2016 Sep;109(9):588-91. PMID: 27598370.
p. 35 of 45 Robinna G. Lorenz
73. Cao W, Pham HP, Williams LA, McDaniel J, Siniard RC, Lorenz RG, Marques MB, and Zheng XL. Human neutrophil peptides and complement factor Bb in pathogenesis of acquired autoimmune thrombotic thrombocytopenic purpura. Haematologica. 2016 Nov;101(11):1319-1326. PMID: 27662014. PMCID:PMC5394873
74. Tanner SM, Daft JG, Hill SA, Martin CA, and Lorenz RG. Altered T cell balance in lymphoid
organs of a mouse model of colorectal cancer. J Histochem. Cytochem. 2016 Dec;64(12):753-767. Epub 2016 Oct 20. PMID: 27798287. PMCID: PMC5131745.
75. Remick DG, Lorenz RG, and Smith BR. Opportunity: Newly created physician-scientist
research pathway by the American Board of Pathology. Academic Pathology. 2016;3:1-3. PMID: 28725759. PMCID: PMC5497862.
76. Weaver AN, McCaw TR, Fifolt M, Hites L, and Lorenz RG. The impact of elective versus
required medical school research experiences on career outcomes. Journal of Investigative Medicine. 2017; 2017 Mar 7. pii: jim-2016-000352. doi: 10.1136/jim-2016-000352. PMID: 28270407. PMCID: PMC5833985
77. Staley EM, Simmons SC, Feldman AZ, Lorenz RG, Marques MB, Williams LA, Zheng XL, and Pham HP. Management of chronic myeloid leukemia in the setting of pregnancy: When Is leukocytapheresis appropriate? A case report and review of the literature. Transfusion. 2018; 58:456-460. Dec 11. doi: 10.1111/trf.14448. [Epub ahead of print]. PMID: 29230832.
78. Cao W, Kayama H, Chen ML, Delmas A, Sun A, Kim SY, Rangarajan ES, McKevitt K, Beck AP, Jackson CB, Crynen G, Oikonomopoulos A, Lacey PM, Martinez GJ, Izard T, Lorenz RG, Rodriguez-Palacios A, Cominelli F, Abreu MT, Hommes DW, Koralov SB, Takeda K, and Sundrud MS. The xenobiotic transporter Mdr1 enforces T cell homeostasis in the presence of intestinal bile acids. Immunity. 2017;47(6):1182-1196.e10. PMID: 29262351. PMCID: PMC5741099.
79. Lorenz RG, Karcher DS, Gautreaux MD, Limson M, and Zander DS, for the PhD Data Task Force. The pathology workforce and clinical licensure: The role of the PhD clinical laboratorian in the United States. Academic Pathology. 2018;5:1-8.
80. Shen JZ, Hill BC, Polhill SR, Evans PA, Galloway DP, Johnson RB, Reddy VVB, Bosarge PL, Rice-Jennings LA, and Lorenz RG. Optimization of Laboratory Ordering Practices for Complete Blood Count with Differential. American Journal of Clinical Pathology. 2018. Oct 24 (Epub ahead of print).
81. Staley DM, Cao W, Pham HP, Kim CH, Kocher NK, Zheng L, Gangaraju R, Lorenz RG,
Williams LA, Marques MB, and Zheng XL. Clinical Factors and Biomarkers Predicting Outcome in Patients with Immune-Mediated Thrombotic Thrombocytopenic Purpura. Haematologica. 2018. Aug 31. pii: haematol.2018.198275. doi: 10.3324/haematol.2018.198275. [Epub ahead of print].
WM, and Lorenz RG. Gamification: An Innovative Approach to Reinforce Clinical
p. 36 of 45 Robinna G. Lorenz
Knowledge for MD-PhD Students During Their PhD Research Years. Medical Science Educator. https://doi.org/10.1007/s40670-019-00725-1. [Epub ahead of print].
In Press Submitted Stoll, M, Maynard C., Pierce M, Van Der Pol W, and Lorenz RG. Perinatal exposure to dioxins affects the contents of the microbiota and development of arthritis in the (KRN/B6 x NOD) F1 model of rheumatoid arthritis. Zheng L, Cao W, Staley EM, Pham HP, Lorenz RG, Marques MB, Williams LA, and Zheng XL. Histone-DNA Complexes Trigger Thrombotic Thrombocytopenic Purpura. Liang Zheng, Wenjing Cao, Mohammad S. Abdelgawwad, Elizabeth M. Staley, Huy P. Pham, Robin G. Lorenz, Marisa B. Marques, Lance A. Williams, and X. Long Zheng. Lysine-Histone Triggers Thrombotic Thrombocytopenic Purpura in Adamts13-/- Zebrafish Other Publications 83. Lorenz RG, and Allen PM: Antigen processing and presentation of ribonuclease and fibrinogen.
In: Antigen Presenting Cells: Diversity, Differentiation, and Regulation. L.B. Schook and J.G. Tew, Eds. Alan R. Liss, Inc. New York, NY, pp. 77-82, 1988.
84. Lorenz RG, and Allen PM: Processing and presentation of self proteins. Immunol. Rev.
1988;106:115-127. 85. Lorenz RG, Chen JS, Williams SA, and Allen PM: The binding of self antigens to Ia molecules.
Cold Spring Harbor Symposium on Quantitative Biology. 1989;54:453-458. 86. Schilling JD, Hultgren SJ, and Lorenz RG,: Recent advances in the molecular basis of pathogen
recognition and host responses in the urinary tract. Int. Rev. Immunol. 2002;21:291-304. 87. Elson CO, Cong Y, Lorenz R, and Weaver CR: New developments in experimental models of
Assessing the quality of immunoassay systems: Radioimmunoassays, and enzyme, fluorescence, and luminescence immunoassays; approved guideline . NCCLS document I/LA23-A, 2004.
89. Newberry RD and Lorenz RG: Organizing a mucosal defense. Imm. Rev. 2005; 206:6-21.
p. 37 of 45 Robinna G. Lorenz
90. Elson CO, Cong Y, McCracken, VJ, Dimmitt, RA, Lorenz, RG, and Weaver, CT: Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota. Imm. Rev. 2005; 206:260-276.
91. Lorenz RG, McCracken, VJ, and Elson CO: Animal models of intestinal inflammation:
inefective communication between coalition members. Springer Sem. Immunopath. 2005:27:233-247.
92. Lorenz RG: Celiac Disease: How serological tests can improve diagnosis. Clinical Laboratory
News. 2007;33:10-11. 93. Lorenz RG: Commentary on Clinical Case Study (Celiac Disease Refractory to a Gluten-free
(Clinical and Translational Science Network), November 26, 2010; http://community.sciencecareers.org/ctscinet/articles/2010/11/perspective-residency-101-for-physician-scientists.php.
95. Sofi MH, Johnson BM, Gudi R, Wolf KJ, Lorenz RG, Vasu C: Response to Comment on Sofi et
al. pH of Drinking Water Influences the Composition of Gut Microbiome and Type 1 Diabetes Incidence. Diabetes 2014;63:632-644. Diabetes. 2015 Aug;64(8):e20-1. doi: 10.2337/db15-0554. PMCID: 26207043
BOOKS:
1. Stenson WF, Newberry RD, and Lorenz RG: Immunologic diseases of the gastrointestinal tract. In: Samter’s Immunologic Diseases, Sixth Edition K.F. Austin and M.M. Frank, Eds. Lippincott Williams & Wilkins, Baltimore, MD, pp. 693-711, 2001.
2. Elson EO, Cong Y, Lorenz RG and Weaver CT: Pathogenesis of inflammatory bowel
disease: The bacterial connection. In: Old Herborn University Seminar Monograph, 18:11-22, 2005.
3. Nahm MH and Lorenz RG: Functional assays for B cells and antibodies. In: Manual of
Molecular and Clinical Laboratory Immunology 7th Ed., Ch. 37, pp. 328-336, B Detrick, RG Hamilton, JD Folds, Eds. ASM Press, Washington, D.C., 2006.
4. Lorenz RG and Elson EO: Microbial sensing in the intestine by pattern recognition receptors.
In: Challenges in Inflammatory Bowel Disease 2nd Ed., Ch. 3, pp. 33-43, D Jewell, N Martensen, H Steinhart, B Warren, and J Peberton, Eds. Blackwell Publishing, Oxford, UK, 2006.
5. Lorenz RG and Nahm MH: Quick Guide to Autoimmune Disease Serology. AACC Press, Washington, DC, 2012, ISBN: 9781594251429.
p. 38 of 45 Robinna G. Lorenz
6. Tormey CA, Gehrie EA, Pham HP, Bucy RP, Lorenz RG, Zheng XL, and Hendrickson JE:
Chapter 21: Data interpretation in transfusion medicine. In: Transfusion Medicine, Apheresis, and Hemostasis. Pham HP and Williams L. Elsevier, Inc. Waltham, MA. 2017. ISBN: 9780128039991.
PUBLISHED ABSTRACTS: Newberry RD and Lorenz RG: Antigen-specific interleukin 10 expression is independent of dose or route of antigen administration. Gastroenterology 114 (Part 2, Suppl. S): G4300, 1998. Newberry RD and Lorenz RG: In vivo cytokine expression in intestinal lymphoid compartments of TCR transgenic mice after oral antigen administration. FASEB J. 12 (Part 1, Suppl. S): 3479, 1998. Martin SM, Thomas ML, and Lorenz RG: Mucosal T cell development in CD45 deficient mice. FASEB J. 12 (Part 1, Suppl. S): 1771, 1998. Newberry RD, Stenson WF, and Lorenz RG: A novel model of an intestinal inflammatory response to a dietary antigen. Gastroenterology 116 (Part 2): G3400, 1999. Roth KA, Kapadia SB, Martin SM, and Lorenz RG: Cellular immune responses are essential for the development of Helicobacter-associated gastric pathology. Gastroenterology 116 (Part 2): G3320, 1999. Daly TM, Frisella WA, Sands MS, and Lorenz RG: Neonatal gene transfer in a murine model of lysosomal storage disease. Am. J. Clin. Path. 112, 1999. Guruge JL, Syder AJ, Lorenz RG, Falk PG and Gordon JI: Helicobacter pylori attaches to neuAca2,3galb1,4 glycoconjugates, including the tumor associated antigen sialyl-Lewis(x), produced in the stomach of transgenic mice lacking parietal cells. Gut 45(Suppl. 3): A35, 1999. Martin SM, and Lorenz RG: T lymphocytes in Helicobacter induced gastric epithelial pathology. FASEB J. 14 (Suppl. S): A1059, 2000. Newberry RD, and Lorenz RG: The requirement for lymphotoxin and Peyer's patches in the development of intestinal lamina propria. Gastroenterology 118 (Part 1, Suppl. 2): 1929, 2000. Martin SM, and Lorenz RG: The role of the tumor necrosis factor family of cytokines in the development of precancerous lesions associated with Helicobacter infection. Gastroenterology 118 (Part 1, Suppl. 2): 4090, 2000. Riehl TE, Newberry RD, Lorenz RG, and Stenson WF: Lipopolysaccharide induced radioprotection of the mouse small intestine requires TNF-a and IL-1b. Gastroenterology 120 (Suppl. 1): 443, 2001.
p. 39 of 45 Robinna G. Lorenz
Lorenz RG, Chaplin DD, McDonough J, McDonald KG, and Newberry RD: Isolated lymphoid follicle formation is inducible and dependent upon Lymphotoxin, Lymphotoxin b Receptor, and TNF Receptor I Function. Gastroenterology 124 (Suppl 1):647, 2003. Lorenz RG, McCracken BA, McCracken VJ, and Dimmitt RA: Bacterial-host interactions in the MDR1a-/- model of intestinal inflammation. The Physiologist 47: 236, 2004. Staley EM, Dimmitt RA, Chuang G, Rygiel SD, and Lorenz RG: Developmental changes in T-hleper bias in murine disease models. J. Invest. Med. 54:S283, 2006. Dimmitt RA, Soltau T, Chuang G, and Lorenz RG: Developmental murine intestinal toll-like receptor expression. J. Invest. Med. 54:S307, 2006. Hull M, Dimmitt RA, Staley E, Lorenz RG. Lack of Multi-drug Resistance Gene Expression Increases Toll-like Receptor 9-Mediated Epithelial Immune Response. J. Invest. Med. 55:S280, 2007. Stanus AL and Lorenz RG: Natural Killer Cells Contribute to the Murine Inflammatory Immune Response to Helicobacter Infection. J. Invest. Med. 55:S281, 2007. Wright S, Smythies L, Novak L, Schmitz JM, Lorenz RG, Harris P, and Smith PD: Helicobacter pylori Infection in Children is Associated with a Mucosal T Regulatory Cell Response and Less Severe Gastritis than that of Adults. Gastroenterology 132 (Suppl) 2007. Dimmitt RD and Lorenz RG: Lack of P-glycoprotein expression increases TLR9 mediated epithelial immune response. Gastroenterology 132 (Suppl) 2007. Schmitz JM, Schoeb TR, McCracken VJ, Lorenz RG: “Inflammation is Attenuated In Germ-free C57BL/6 Mice Infected with Helicobacter felis” FASEB J. 22:852.8, 2008. Durham CG and Lorenz RG: Toll-like receptor 2 and 4 sensing in Helicobacter felis infections: implications for an alternative sensing mechanism. FASEB J. 22:852.12, 2008. Dimmitt RD, Seay A, and Lorenz RG: P-glycoprotein deficient dendritic cells have greater activation following treatment with TLR4 and TLR9 ligands. Gastroenterology 134(supplement 1):A652, 2008. Tatum P, Staley E, Tanner S, and Lorenz R: The role of TLR2 and TLR44 in postnatal intestinal development. Mucosal Immunology 2(supplement 1):S4(Epithelium/Barrier & Innate Immunity, 2009. Daft JG, Wolf KJ, and Lorenz RG: Alterations in intestinal antimicrobial peptides are associated with increased susceptibility to type 1 diabetes. Gastroenterology 140(5)(supplement 1):S500 (Su1808). 2011.
p. 40 of 45 Robinna G. Lorenz
Tanner SM and Lorenz RG: Decreased Regulatory T Cell Numbers in the Intestine Preceed the Development of Colitis in the Fvb.Mdr1a-/- Mouse. Gastroenterology 140(5)(supplement 1):S487 (Su1746). 2011. Tanner S, Hill S, Martin C, and Lorenz R: Altered CD4+ T cell subset balance in lymphoid organs of mouse model of colorectal cancer. FASEB J April 2014 28:397.2. Daft J and Lorenz R: Antimicrobial peptide and mucin expression differ between the diabetic NOD mouse and non-diabetic NOR mouse. FASEB J April 2014 28:650.16. Tanner SM, Lorenz RG, and Martin CA: Aryl hydrocarbon receptor disrupts B1 cell populations and antibody production in intestinal tissue. Gastroenterology May 2014 146(5):S-294. Kennell T, Laufer V, Lorenz R, and Park S: This is Your Brain on Informatics: A Total-Immersion Data Sciences Course for the Next Generation of Informaticists. Abstracts: Pathology Informatics 2014. J Pathol Inform 2014;5:20. Lorenz RG, Tanner S, Daft J, and Little M: Antimicrobial peptide gene expression and functionality in P-glycoprotein deficient models of colitis (MUC3P.943). J. Immunol. 2015 194:66.2 Abstract MUC3P.943. POSTER EXHIBITS: Martin SM, Madison BB, Goodwin-Watkins KM, Thomas ML, and Lorenz RG: Panenteritis and abnormal mucosal lymphoid compartments in CD45 exon 6 deficient mice. Innate and Adaptive Immune Responses at Mucosal Surfaces, Keystone Symposium 1997, Santa Fe, NM. Chen D, and Lorenz RG: Gastric expression of major histocompatibility complex class II molecules. Innate and Adaptive Immune Responses at Mucosal Surfaces, Keystone Symposium 1997, Santa Fe, NM. Newberry RD, and Lorenz RG: In vivo expression of TGF-b, IL-2, and IFN-g in ovalbumin fed mice. Innate and Adaptive Immune Responses at Mucosal Surfaces, Keystone Symposium 1997, Santa Fe, NM. Martin SM, Thomas ML, and Lorenz RG: Mucosal T cell development in CD45 deficient mice. Annual FASEB Meeting, 1998, San Francisco, CA. Roth KA, Kapadia SB, Martin SM, and Lorenz RG: Cellular immune responses are essential for the development of Helicobacter-associated gastric pathology. First Harry and Elsa Jiler American Cancer Society Professor Meeting, October 1999, White Plains, NY.
p. 41 of 45 Robinna G. Lorenz
Newberry RD, Stenson WF, and Lorenz RG: A novel model of an intestinal inflammatory response to a dietary antigen. Digestive Disease Week and the 100th Annual Meeting of the American Gastroenterological Association, May 1999, Orlando, FL. Roth KA, Kapadia SB, Martin SM, and Lorenz RG: Cellular immune responses are essential for the development of Helicobacter-associated gastric pathology. Digestive Disease Week and the 100th Annual Meeting of the American Gastroenterological Association, May 1999, Orlando, FL. Martin SM, and Lorenz RG: T lymphocytes in Helicobacter induced gastric epithelial pathology. Annual Meeting of the American Association of Immunologists, 2000, Seattle, WA. Newberry RD, and Lorenz RG: The requirement for lymphotoxin and Peyer's patches in the development of intestinal lamina propria lymphocytes (Poster of Distinction). Digestive Disease Week and the 101st Annual Meeting of the American Gastroenterological Association, May 2000, San Diego, CA. Martin SM, and Lorenz RG: The role of the tumor necrosis factor family of cytokines in the development of precancerous lesions associated with Helicobacter infection. Digestive Disease Week and the 101st Annual Meeting of the American Gastroenterological Association, May 2000, San Diego, CA. McCracken VJ, and Lorenz RG: Helicobacter felis-induced gastric inflammation is attenuated in B6.lpr and B6.gld mice. 101st Annual Meeting of the American Society for Microbiology, May 2001, Orlando, FL. Martin SM, and Lorenz RG: NK cell, NK-T cell and iIEL development in the absence of CD45. Interfaces between inate and adaptive immunity, Keystone Symposium 2001, Keystone, CO. Schmitz JM and Lorenz RG: Evaluation of Mucins and Trefoil Factors Over the Course of Helicobacter Infection. 12th International Congress of Mucosal Immunology, 2005, Boston, MA. McCracken VJ and Lorenz RG: Protection from IBD by gastric helicobacter. 12th International Congress of Mucosal Immunology, 2005, Boston, MA. Schmitz JM and Lorenz RG: Gastrointestinal Expression of CXCL15 (Lungkine). Immunology 2006, Boston, MA. Dimmitt RD and Lorenz RG: Lack of P-glycoprotein expression increases TLR9 mediated epithelial immune response. Digestive Disease Week 2007, Los Angeles, CA. Durham CG and Lorenz RG: Toll-like receptor 2 and 4 sensing in Helicobacter felis infections: implications for an alternative sensing mechanism. Experimental Biology 2008, San Diego, CA. Dimmitt RD, Seay A, and Lorenz RG: P-glycoprotein deficient dendritic cells have greater activation following treatment with TLR4 and TLR9 ligands. Digestive Disease Week 2008, San Diego, CA.
p. 42 of 45 Robinna G. Lorenz
Durham CG and Lorenz RG: Toll-like receptor 2 and 4 in cockroach antigen-induced asthma: a potential mechanism for establishing a Th1 phenotype. Immunology 2009, Seattle, WA. Durham CG, Schmitz JM, Schoeb TR, Soltau TD, Wolf KJ, McCrackenVJ, and Lorenz RG: Helicobacter felis-associated gastric pathology in gnotobiotic mice. Immunology 2010, Baltimore, MD. Daft JG and Lorenz RG: Intestinal barrier function and susceptibility to diabetes in the NOD mouse. Gastrointestinal Response to Injury Conference. 2010. Scottsdale, AZ. Tanner SM and Lorenz RG: Altered intestinal homing molecule expression prevents effective Treg trafficking in the FVB.mdr1a-/- model of colitis. Immunology 2010, Baltimore, MD. Wolf KJ and Lorenz RG: Dietary Alteration of Intestinal Microbiota alters incidence of Type 1 Diabetes. American Diabetes Association 70th Scientific Sessions, Orlando, FL. 2010 Daft JG and Lorenz RG: Alterations in intestinal antimicrobial peptides are associated with increased susceptibility to Type 1 Diabetes. Digestive Disease Week, Chicago, IL. 2011. Tanner SM and Lorenz RG: Decreased regulatory T cell numbers in the intestine precede the development colitis in the FVB.mdr1a-/- mouse. Digestive Disease Week, Chicago, IL. 2011. Wolf KJ and Lorenz RG: Diet Associated Changes in Type 1 Diabetes are Correlated with Altered Intestinal Microbial Diversity. 111th General Meeting of the American Society for Microbiology, New Orleans, LA. 2011. Wolf KJ and Lorenz RG: Intestinal microbial composition is a determining factor in onset of type-1 diabetes in NOD mice. 2012 Federation of Clinical Immunology Societies, Vancouver, British Columbia. Contreras D and Lorenz R: Inflammatory Th-17 cells in the mouse model of colitis. Annual Biomedical Research Conference for Minority Students, San Jose, CA. 2012. Tanner SM, Lorenz RG, and Martin CA: Aryl hydrocarbon receptor disrupts B1 cell populations and antibody production in intestinal tissue. Digestive Disease Week 2014, Chicago, IL. Culbreath C, Tanner S, Berryhill T, Lorenz RG and Martin CA. Environmental Mediated Intestinal Homeostasis In Neonatal Mice. 10th Annual Academic Surgical Congress, February 3-4, 2015, Las Vegas, NV. Lorenz RG, Tanner S, Daft J, and Little M: Antimicrobial peptide gene expression and functionality in P-glycoprotein deficient models of colitis (MUC3P.943). Immunology 2015, New Orleans, LA (May 2015).
p. 43 of 45 Robinna G. Lorenz
Geisler WM and Lorenz RG: A Continuing Clinical Education Course to Maintain Clinical Competencies and Foster New Clinical Knowledge During the Graduate School Years of MD/PhD Training. 2015 National Association of MD-PhD Programs Annual Meeting (Keystone, CO; July 2015). Marques MB, Lorenz RG, and Williams LA: High percentage of evanescent red cell antibodies in patients with sickle cell disease highlights the need for a national antibody database. 57th American Society of Hematology Annual Meeting (Orlando, FL; December 2015). Cao W, Pham HP, Williams LA, Ping Z, Lorenz RG, Marques M, and Zheng XL. Alterations of Plasma Levels of Human Neutrophil Peptides and Complement Activation Markers in Patients with Acquired Autoimmune Thrombotic Thrombocytopenic Purpura. 57th American Society of Hematology Annual Meeting (Orlando, FL; December 2015). Pham HP, Williams LA, Lorenz RG, Marques M, and Zheng XL. Predictors for in-Hospital Mortality in Patients with Autoimmune Thrombotic Thrombocytopenia Purpura (TTP): A Single Center Experience. 58th American Society for Hematology Annual Meeting (San Diego, CA; December 2016). Pham HP, Cao W, Williams LA, Ping Z, Feldman AZ, Staley EM, Siniard RC, Lorenz RG, Marques MB, and Zheng XL. Predictors for 30-day mortality in patients with acquired autoimmune thrombotic thrombocytopenia purpura (TTP): A single center experience. 2016 American Association of Blood Banks (AABB) Meeting (Orlando, FL; October 2016). Staley EM, Pham HP, Cao W, Raju D, Williams LA, Feldman AZ, , Siniard RC, Boshell MN, Lorenz RG, Marques MB, and Zheng XL. Predictors for In-hospital mortality in patients with autoimmune thrombotic thrombocytopenia purpura (TTP): A single center experience. 2016 American Society for Hematology (ASH) Annual Meeting (San Diego, CA; December 2016). ORAL PRESENTATIONS (presented by 1st author): Riehl TE, Newberry RD, Lorenz, RG and Stenson WF: Lipopolysaccharide induced radioprotection of the mouse small intestine requires TNF-a and IL-1b. Digestive Disease Week and the 102nd Annual Meeting of the American Gastroenterological Association, May 2001, Atlanta, GA. Robin G Lorenz, David D. Chaplin, Jacquelyn McDonough, Keely G. McDonald, Rodney Newberry: Isolated Lymphoid Follicle Formation is Inducible and Dependent Upon Lymphotoxin, Lymphotoxin Ɇ Receptor, and TNF Receptor I Function. Digestive Disease Week and the 104th Annual Meeting of the American Gastroenterological Association, May 2003, Orlando, FL. Staley EM, Dimmitt RA, Chuang G, Rygiel SD, and Lorenz RG: Developmental changes in T-helper bias in murine disease models. Southern Society for Pediatric Research Regional Meeting, 2006, Atlanta, GA.
p. 44 of 45 Robinna G. Lorenz
Dimmitt RA, Soltau T, Chuang G, and Lorenz RG: Developmental murine intestinal toll-like receptor expression. Southern Society for Pediatric Research Regional Meeting, 2006, Atlanta, GA. Dimmitt RA, Kimbrough C, and Lorenz RG: Colitis in Wild-type Mice Following Neonatal Bone Marrow Tansfer with mdr1a-/- Hematopoietic Stem Cells. Digestive Disease Week 2006, Los Angeles, CA. Hull M, Dimmitt RA, Staley E, Lorenz RG. Lack of Multi-drug Resistance Gene Expression Increases Toll-like Receptor 9-Mediated Epithelial Immune Response. Southern Society for Pediatric Research Regional Meeting, 2007, New Orleans, LA. Stanus AL and Lorenz RG: Natural Killer Cells Contribute to the Murine Inflammatory Immune Response to Helicobacter Infection. Southern Society for Pediatric Research Regional Meeting, 2007, New Orleans, LA. Wright S, Smythies L, Novak L, Schmitz JM, Lorenz RG, Harris P, and Smith PD: Helicobacter pylori Infection in Children is Associated with a Mucosal T Regulatory Cell Response and Less Severe Gastritis than that of Adults. Digestive Disease Week 2007, Los Angeles, CA. Schmitz JM, Schoeb TR, McCracken VJ, Lorenz RG: “Inflammation is Attenuated In Germ-free C57BL/6 Mice Infected with Helicobacter felis” Experimental Biology 2008, San Diego, CA. Tanner SM and Lorenz RG: “Altered intestinal homing molecule expression prevents effective Treg trafficking in the FVB.mdr1a-/- model of colitis.” 14th International Congress of Immunology. Kobe, Japan. 2010. Tanner SM and Lorenz RG: “Fewer Foxp3+ regulatory T cells in the intestines of FVB.mdr1a-/- mice may result in colitis.” University of North Carolina Translational Medicine Symposium. Chapel Hill, NC, USA. 2010. Daft JG and Lorenz RG: “CBir1 Flagellin and the modulation of type 1 diabetes.” Midwestern Islet Club (MIC) annual meeting. 2012. Pittsburgh PA. Tanner SM and Lorenz RG: “Decreased regulatory T cell numbers in the intestine precede the development of colitis in the FVB.mdr1a-/- mouse.” The Histochemical Society: 63rd Annual Meeting, Woods Hole, MA. 2012. Geisler WM, Weaver AN, Allen H, Brosius S, Poholek C, Fox B, and Lorenz RG: “A continuing clinical education course to maintain clinical competencies and foster new clinical knowledge during the graduate school years of MD/PhD Training.” 2015 MD/PhD Association National Meeting, Keystone, CO. July 2015. Cao W, Pham H, Williams LA, Siniard RC, Lorenz R, Marques MB, and Zheng XL: “Increased plasma levels of human neutrophil peptides (HNPs) and complement activation markers in
p. 45 of 45 Robinna G. Lorenz
patients with acquired Thrombotic Thrombocytopenic Purpura (TTP).” Lab Medicine 2016: Annual Meeting of the Academy of Clinical Laboratory Physicians and Scientists (ACLPS), Birmingham, AL. June 2016.
